Name | CD44 |
---|---|
Synonyms | CD44; LHR; Heparan sulfate proteoglycan; CD44 antigen; CD44 antigen (Indian blood group); CD44 antigen (homing function and Indian blood group system); CD44 antigen precursor; CD44 molecule (Indian blood group)… |
Name | SMA |
---|---|
CAS | sodium 2-chloroacetate |
PubMed | Abstract | RScore(About this table) | |
---|---|---|---|
20223349 | Defaud-Henon F, Tunon-de-Lara C, Fournier M, Marty M, Velasco V, de Mascarel I, MacGrogan G: [Adenoid cystic carcinoma of the breast: clinical, histological and immunohistochemical characterization]. Ann Pathol. 2010 Feb;30(1):7-16. Epub 2010 Feb 18. An immunohistochemical study was performed with the following antibodies: ER, PR, HER-2-neu, Vimentin, EGFR, P63, SMA, CK5/6, CK8/18, CK14, cKIT, MIB1, CD44 and CD24. |
1(0,0,0,1) | Details |
18990339 | Wang XB, Liu P, Tang ZP, Li FH, Liu CH, Hu YY, Xu LM: [Cordyceps mycelia extract decreases portal hypertension in rats with dimethylnitrosamine-induced liver cirrhosis: a study on its histological basis]. Zhong Xi Yi Jie He Xue Bao. 2008 Nov;6(11):1136-44. The expressions of CD44, von Willebrand factor (vWF), laminin (LM), alpha-smooth muscle actin (alpha-SMA), type I collagen (Col I) and type IV collagen (Col IV) proteins in the hepatic sinusoida l walls were examined by immunohistochemistry. |
2(0,0,0,2) | Details |
20131370 | Johnson BQ, Fox R, Chen X, Thibeault S: Tissue regeneration of the vocal fold using bone marrow mesenchymal stem cells and synthetic extracellular matrix injections in rats. Laryngoscope. 2010 Mar;120(3):537-45. RESULTS: BM-MSC grown in vitro within sECM express Sca-1, are positive for receptor CD44, and continue to proliferate. |
1(0,0,0,1) | Details |
18590220 | Zhu M, Gao JH, Lu F: [Cell biological study of cultured cells derived from the fattyoffluid portions of liposuction aspirates]. Zhonghua Zheng Xing Wai Ke Za Zhi. 2008 Mar;24(2):138-44. CD29, CD44, CD34, which were the markers of mesenchymal stem cells, vWF, CD31, CD105, SMA were all expressed in ASCs. |
1(0,0,0,1) | Details |